Sarcoid-Like Reactions to Immune Checkpoint Inhibitors: Incidence, Treatment Course, and Impact on Cancer Progression and Survival
CONCLUSIONS: SLRs are a known but understudied complication associated with ICI therapy. Multisystem SLR patients were more symptomatic and required ICI discontinuation and immune suppression. Larger studies are needed to fully evaluate the impact of SLR on cancer outcomes.PMID:38648910 | DOI:10.1016/j.rmed.2024.107640
Source: Respiratory Care - Category: Respiratory Medicine Authors: Hannah Smith Robert Easterling Jianing Ma Meghana Moodabagil Alexa Meara Dwight H Owen Elliot Crouser Arindam Singha Kevin Ho Source Type: research
More News: Academia | Cancer | Cancer & Oncology | Corticosteroid Therapy | Lung Cancer | Melanoma | Non-Small Cell Lung Cancer | Respiratory Medicine | Sarcoidosis | Skin Cancer | Study